menu close
www.artivabio.com

Artiva Bio Stock

Company Profile:

Artiva is an immunotherapy company with a mission to deliver to cancer patients highly effective cellular immunotherapies that are safe and immediately accessible. The company is advancing a pipeline of off-the-shelf, allogeneic NK cell therapies, for the treatment of hematologic cancers or solid tumors.

Sign up today for more details and to buy or sell Artiva Bio Stock
Buy + Sell

Artiva Bio Funding

Gain insight into Artiva Bio funding rounds, the table below shows Artiva Bio capital raises and the dates of Artiva Bio financing history.

Sign Up to Unlock the Data
Date Financing Round Amount Price per share* Valuation*
Jul 10, 2020Series A$43.44M
Price
Valuation
Feb 22, 2021Series B$120.00M
Price
Valuation

*Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market Tape D™

Leverage Your Equity to Help Achieve More.

Artiva Bio Management Team

  • Director

    Bong Koh

  • Director

    Yvonne Yamanaka

  • Director

    Elizabeth Hougen

  • Director

    Edith A. Perez

  • CEO, President, Director

    Fred Aslan

  • Director

    Brian Daniels

  • Director

    Laura Bessen

  • Director

    Laura Stoppel

  • Co-Founder, Strategic Advisor

    Peter Flynn

  • Director

    James Park

  • Director

    Linda Kozick

  • Chief Medical Officer

    Thorsten Graef

  • Chief Technical Operations Officer

    Christopher Horan

  • Director

    Yong-Jun Huh

  • EVP, Chief Legal and People Officer

    Jennifer Bush

Artiva Bio Major Investors

  • Venrock, Inc.

  • RTW Investments

  • Janus Henderson

  • Medivate Partners

  • 5AM Ventures

  • EcoR1 Capital

  • Surveyor Capital - Citadel

  • venBio Partners LLC

  • Cormorant Asset Management

  • Logos Capital

  • Acuta Capital Partners

  • Wellington Management Company LLP

  • RA Capital Management LLC

  • Franklin Templeton

  • Green Cross Corp

Learn More About Artiva Bio Stock

Buy Artiva Bio Stock
01
Artiva Bio stock does not trade on public stock exchanges. Artiva Bio stock is considered a private security and you need to be an accredited investor to purchase shares. To invest in Artiva Bio stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market. Get started to begin exploring private market opportunities.
Sell Artiva Bio Stock
02
Artiva Bio Stock does not trade on public stock exchanges. In order to sell Artiva Bio shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors. Get started to begin exploring private market opportunities.
Artiva Bio Stock Price
03
Artiva Bio does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view Artiva Bio share price and other valuable private market data. Get started to begin exploring the Nasdaq Private Market Tape D™ database.
Artiva Bio Stock Ticker Symbol
04
There is no ticker symbol for Artiva Bio stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company “street” name or legal name. Get started to begin exploring the Nasdaq Private Market Tape D™ database.
Criteria to Sell Artiva Bio Stock
05
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Artiva Bio stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Criteria to Buy or Invest in Artiva Bio Stock
06
Currently, Nasdaq Private Market only works with institutional investors to purchase private company stock. In order to invest in Artiva Bio stock you need to be an institutional investor. Get started to begin exploring the Nasdaq Private Market Tape D™ database.
Artiva Bio Stock Settlement
07
Once you buy or sell stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
Artiva Bio IPO
08
Artiva Bio is a private company and has not had an IPO. There is currently no Artiva Bio IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Artiva Bio IPO.
Sign up today for more details and to buy or sell Artiva Bio Stock
Buy + Sell

Other Companies

Arctic Wolf

Cloud-based network security services.

Cityblock Health

Tech-driven care provider for communities with complex needs.

Traceable

API Security company.

Beyond Limits

Hybrid artificial intelligence company combining generative AI and machine learning with knowledge-based reasoning.

Gradiant

End-to-end water treatment and digital solutions.

Ethos Technologies

Life insurance product provider.

Source: Nasdaq Private Market Tape D™